Medicinal mishap

Following the announcement of the verdict in the ongoing Johnson & Johnson baby powder case, the company’s stock shares fell 1.4%. In the Missouri joint lawsuit, 22 women claimed a direct correlation between their long-term use of Johnson & Johnson baby powder and their ovarian cancer diagnoses. A jury agreed with the evidence and testimony presented in the lawsuit and awarded $4.69 billion to the women. This compensation amount placed this lawsuit as the 6^th largest product-defect verdict in the history of the US.  Johnson & Johnson is fighting back and is confident that the verdict will reverse in an appeal.  Continue reading →